RSS feed

Publications by Dag R. Sørensen

24 publications found

Original articles

Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G (2010)
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
Am J Pathol, 177 (6), 2804-15
DOI 10.2353/ajpath.2010.100378, PubMed 21037074

Iversen PO, Sørensen DR, Sioud M (2010)
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
Thromb Haemost, 104 (2), 350-4
DOI 10.1160/TH09-12-0816, PubMed 20539915

Sørensen DR, Sioud M (2010)
Systemic delivery of synthetic siRNAs
Methods Mol Biol, 629, 87-91
DOI 10.1007/978-1-60761-657-3_6, PubMed 20387144

Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
Transl Oncol, 2 (4), 242-6
DOI 10.1593/tlo.09154, PubMed 19956385

Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G (2008)
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Am J Pathol, 173 (4), 1229-42
DOI 10.2353/ajpath.2008.080014, PubMed 18787100

Iversen PO, Sørensen DR (2007)
A murine model for studying hematopoiesis and immunity in heart failure
Methods Mol Biol, 360, 269-75
DOI 10.1385/1-59745-165-7:269, PubMed 17172734

Iversen PO, Sørensen DR, Tronstad KJ, Gudbrandsen OA, Rustan AC, Berge RK, Drevon CA (2006)
A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia
Clin Cancer Res, 12 (11 Pt 1), 3525-31
DOI 10.1158/1078-0432.CCR-05-2802, PubMed 16740779

Torp R, Singh PB, Sørensen DR, Dietrichs E, Hirschberg H (2006)
[Growth factors as neuroprotective treatment in Parkinson disease?]
Tidsskr Nor Laegeforen, 126 (7), 899-901
PubMed 16554879

Hirschberg H, Sørensen DR, Angell-Petersen E, Peng Q, Tromberg B, Sun CH, Spetalen S, Madsen S (2006)
Repetitive photodynamic therapy of malignant brain tumors
J Environ Pathol Toxicol Oncol, 25 (1-2), 261-79
DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.170, PubMed 16566723

Skovseth DK, Veuger MJ, Sorensen DR, De Angelis PM, Haraldsen G (2004)
Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo
Blood, 105 (3), 1044-51
DOI 10.1182/blood-2004-03-1164, PubMed 15466935

Sioud M, Sørensen DR (2004)
Systemic delivery of synthetic siRNAs
Methods Mol Biol, 252, 515-22
DOI 10.1385/1-59259-746-7:515, PubMed 15017077

Sioud M, Sørensen DR (2003)
Cationic liposome-mediated delivery of siRNAs in adult mice
Biochem Biophys Res Commun, 312 (4), 1220-5
DOI 10.1016/j.bbrc.2003.11.057, PubMed 14652004

Sørensen DR, Leirdal M, Sioud M (2003)
Gene silencing by systemic delivery of synthetic siRNAs in adult mice
J Mol Biol, 327 (4), 761-6
DOI 10.1016/s0022-2836(03)00181-5, PubMed 12654261

Lehne G, Sørensen DR, Tjønnfjord GE, Beiske C, Hagve TA, Rugstad HE, Clausen OP (2002)
The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
Leukemia, 16 (12), 2388-94
DOI 10.1038/sj.leu.2402663, PubMed 12454743

Iversen PO, Sorensen DR, Benestad HB (2002)
Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias
Leukemia, 16 (3), 376-81
DOI 10.1038/sj.leu.2402376, PubMed 11896541

Sorensen DR, Read TA, Porwol T, Olsen BR, Timpl R, Sasaki T, Iversen PO, Benestad HB, Sim BK, Bjerkvig R (2002)
Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma
Neuro Oncol, 4 (1), 1-8
DOI 10.1093/neuonc/4.1.1, PubMed 11772427

Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
Neoplasia, 4 (6), 474-9
DOI 10.1038/sj.neo.7900271, PubMed 12407440

Read TA, Sorensen DR, Mahesparan R, Enger PO, Timpl R, Olsen BR, Hjelstuen MH, Haraldseth O, Bjerkvig R (2001)
Local endostatin treatment of gliomas administered by microencapsulated producer cells
Nat Biotechnol, 19 (1), 29-34
DOI 10.1038/83471, PubMed 11135548

Behrens GH, Petersen PM, Grotmol T, Sørensen DR, Torjesen P, Tretli S, Haugen TB (2000)
Reproductive function in male rats after brief in utero exposure to diethylstilboestrol
Int J Androl, 23 (6), 366-71
DOI 10.1046/j.1365-2605.2000.00254.x, PubMed 11114983

Sioud M, Sørensen DR (1998)
A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
Nat Biotechnol, 16 (6), 556-61
DOI 10.1038/nbt0698-556, PubMed 9624687

Satas S, Johannessen SI, Hoem NO, Haaland K, Sørensen DR, Thoresen M (1997)
Lidocaine pharmacokinetics and toxicity in newborn pigs
Anesth Analg, 85 (2), 306-12
DOI 10.1097/00000539-199708000-00012, PubMed 9249105

Tyler NJ, Hotvedt R, Blix AS, Sørensen DR (1990)
Immobilization of Norwegian reindeer (Rangifer tarandus tarandus) and Svalbard Reindeer (R. t. platyrhynchus) with medetomidine and medetomidine-ketamine and reversal of immobilization with atipamezole
Acta Vet Scand, 31 (4), 479-88
DOI 10.1186/BF03547531, PubMed 1983084

Review articles

Sorensen DR, Read TA (2002)
Delivery of endostatin in experimental cancer therapy
Int J Exp Pathol, 83 (6), 265-74
DOI 10.1046/j.1365-2613.2002.00240.x, PubMed 12657135

Theses

Sørensen DR (2002)
Experimental therapy of a rat gliosarcoma: with special emphasis on angiogenesis
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 69, 1 b. (flere pag)
BIBSYS 022956212, ISBN 82-8072-042-1